175 related articles for article (PubMed ID: 22882756)
1. The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation.
Tripodi A; Moia M
J Thromb Haemost; 2012 Oct; 10(10):2207-8. PubMed ID: 22882756
[No Abstract] [Full Text] [Related]
2. The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal.
Schulman S; Crowther M; Holbrook A
J Thromb Haemost; 2013 Mar; 11(3):566-7. PubMed ID: 23279332
[No Abstract] [Full Text] [Related]
3. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
Denas G; Cucchini U; Iliceto S; Pengo V
Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
[No Abstract] [Full Text] [Related]
4. Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.
Pautas E; Peyron I; Bouhadiba S; Golmard JL; Gouronnec A; Oboa N; Siguret V; Gouin-Thibault I
Am J Med; 2011 Jun; 124(6):527-33. PubMed ID: 21605730
[TBL] [Abstract][Full Text] [Related]
5. International Normalized Ratio in patients not on vitamin K antagonists.
Keeling D
J Thromb Haemost; 2007 Jan; 5(1):188-9. PubMed ID: 17067366
[No Abstract] [Full Text] [Related]
6. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Ansell J; Hirsh J; Hylek E; Jacobson A; Crowther M; Palareti G
Chest; 2008 Jun; 133(6 Suppl):160S-198S. PubMed ID: 18574265
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?
Douketis JD; Spyropoulos AC
J Thromb Haemost; 2010 Mar; 8(3):496-8. PubMed ID: 20040039
[No Abstract] [Full Text] [Related]
8. Dietary vitamin K intake and anticoagulation in elderly patients.
Rohde LE; de Assis MC; Rabelo ER
Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):1-5. PubMed ID: 17143047
[TBL] [Abstract][Full Text] [Related]
9. A survey of oral vitamin K use by anticoagulation clinics.
Libby EN; Garcia DA
Arch Intern Med; 2002 Sep; 162(16):1893-6. PubMed ID: 12196089
[TBL] [Abstract][Full Text] [Related]
10. Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH.
Tripodi A; de Laat B; Wahl D; Ageno W; Cosmi B; Crowther M;
J Thromb Haemost; 2016 Nov; 14(11):2304-2307. PubMed ID: 27860336
[No Abstract] [Full Text] [Related]
11. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
[TBL] [Abstract][Full Text] [Related]
12. Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?
Steib A; Barre J; Mertes M; Morel MH; Nathan N; Ozier Y; Treger M; Samama CM
J Thromb Haemost; 2010 Mar; 8(3):499-503. PubMed ID: 19912513
[TBL] [Abstract][Full Text] [Related]
13. Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review.
Wilson SE; Watson HG; Crowther MA
CMAJ; 2004 Mar; 170(5):821-4. PubMed ID: 14993179
[TBL] [Abstract][Full Text] [Related]
14. [Self-monitoring and self dosing of oral anticoagulant therapy with vitamin K antagonists].
Levi M; de Bruin TA; van der Meer FJ; Cromheecke ME; de Mol BA
Ned Tijdschr Geneeskd; 2001 Dec; 145(48):2313-7. PubMed ID: 11766299
[TBL] [Abstract][Full Text] [Related]
15. INR targets and site-level anticoagulation control: results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
Rose AJ; Berlowitz DR; Miller DR; Hylek EM; Ozonoff A; Zhao S; Reisman JI; Ash AS
J Thromb Haemost; 2012 Apr; 10(4):590-5. PubMed ID: 22288563
[TBL] [Abstract][Full Text] [Related]
16. [Oral administration of intravenous preparation of Vitamin K for excessive anticoagulation due to warfarin].
Lozada Y; Falcone M; Granero R
Medicina (B Aires); 2012; 72(2):115-8. PubMed ID: 22522851
[TBL] [Abstract][Full Text] [Related]
17. PPSB as first choice treatment in the reversal of oral anticoagulant therapy.
Strengers PF; Drenth JC
Acta Anaesthesiol Belg; 2002; 53(3):183-6. PubMed ID: 12461827
[TBL] [Abstract][Full Text] [Related]
18. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for point-of-care home International Normalized Ratio testing in children on vitamin K antagonist therapy.
Bauman ME; Bruce A; Jones S; Newall F; Massicotte MP; Monagle P
J Thromb Haemost; 2013 Feb; 11(2):366-8. PubMed ID: 23217220
[No Abstract] [Full Text] [Related]
20. The effect of vitamin K supplementation on anticoagulant treatment.
Rombouts EK; Rosendaal FR; van der Meer FJ
J Thromb Haemost; 2006 Mar; 4(3):691-2. PubMed ID: 16460460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
